Aerovate Therapeutics, Inc. (AVTE) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts AVTE Hot Sheet
Join SI Premium – FREE
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) reported Q3 EPS of ($0.56), $0.06 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Aerovate Therapeutics, Inc. (AVTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- DA Davidson Reiterates Underperform Rating on c3.ai (AI)
- Take-Two Interactive (TTWO) Reiterated at Buy by StoneX Ahead of November GTA VI Launch
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
